Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Nurse-Led Multidisciplinary Initiative Doubles Follow-Up Routine Visits For HIV PrEP, Research Suggests

    Healio (4/8, Marabito) reports, “A nurse-led multidisciplinary initiative targeted at providers and medical staff doubled the number of patients who scheduled a follow-up routine visit for HIV preexposure prophylaxis [PrEP],” according to research present...
    Full Article
  • US COVID-19 Death Toll May Soon Surpass 1M

    The AP (4/13, Geller) reports that “soon, likely in the next few weeks, the U.S. toll from the coronavirus will surpass” the “once unthinkable milestone” of one million deaths. COVID-19 has also “left an estimated 194,000 children in the U.S. without one...
    Full Article
  • Pfizer May Develop COVID-19 Vaccine That Protects Against Omicron, Older Variants By Fall, CEO Says

    Reuters (4/13, Erman) reports, “Pfizer Chief Executive Albert Bourla said on Wednesday that the company could possibly develop a new vaccine that protects against the Omicron variant as well as older forms of COVID-19 by autumn.” Bourla explained, “It’s e...
    Full Article
  • Limited Understanding Of T Cells Behind Debate Over Eligibility For Second COVID-19 Booster

    The Wall Street Journal (4/13, Hopkins, Subscription Publication) reports the limited understanding of T cells, which help mount a key immune defense against COVID-19, is driving some of the uncertainty over who should receive a second COVID-19 booster do...
    Full Article
  • Global COVID-19 Cases, Deaths Fall For Third Consecutive Week, WHO Says

    The AP (4/13, Geller) reports, “The number of new coronavirus cases and deaths reported to the World Health Organization fell for a third consecutive week, a trend likely helped by the dismantling of testing and surveillance programs.” The agency “said th...
    Full Article
  • Incidence Of Clostridioides Difficile Infection Higher Among Households With Family Member Recently Discharged From Hospital, Study Indicates

    MedPage Today (4/13, Hamza) reports, “There was a higher incidence of Clostridioides difficile infection among households where a family member was recently discharged from the hospital but not formally diagnosed with such an infection, a study of insuran...
    Full Article
  • Pfizer-BioNTech COVID-19 Vaccine Appears Less Effective Against Omicron Variant, Study Suggests

    The New York Times (12/7, Zimmer, Mueller) reports, “Laboratory experiments found that Omicron seems to dull the power of the Pfizer-BioNTech vaccine, but also hinted that people who have received a booster shot might be better protected.” The study condu...
    Full Article
  • Companies Announce “Positive Efficacy And Safety Results” For First Plant-Based Coronavirus Vaccine

    The Washington Post (12/7, Suliman) reports, “Pharmaceutical companies Medicago and GlaxoSmithKline announced on Tuesday ‘positive efficacy and safety results’ from a global trial using what they say is the world’s first plant-based coronavirus vaccine.”...
    Full Article
  • Selected Metabolic Biomarkers May Influence Disease Risk And Progression In African American And White Persons In Different Ways, Study Indicates

    Medscape (12/7, Kirkner, Subscription Publication) reports, “Selected metabolic biomarkers may influence disease risk and progression in African American and White persons in different ways, a cohort study of the landmark Jackson Heart Study has found.” R...
    Full Article
  • GSK-Vir COVID-19 Therapy Effective Against All Mutations Of Omicron Coronavirus Variant, Data Suggest

    Reuters (12/7, Aripaka) reports GlaxoSmithKline “said on Tuesday its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology...is effective against all mutations of the new Omicron coronavirus variant, citing new data from early-stage studies....
    Full Article
  • Subcutaneous Administration Of Monoclonal Antibodies Works Just As Well As Intravenous Method For COVID-19 Treatment, Researchers Report

    HealthDay (12/7, Thompson) reports, “Monoclonal antibodies have been shown to dramatically reduce risk of hospitalization and death if given within five days of developing symptoms of COVID,” and now, researchers “report that giving monoclonal antibodies...
    Full Article
  • WHO Recommends Against Use Of Blood Plasma From Survivors As Treatment For COVID-19

    The AP (12/7) reports the World Health Organization “recommended Tuesday against using blood plasma from people who have recovered from COVID-19 as a treatment for patients with the illness, saying evidence has not shown the costly, time-consuming transfu...
    Full Article
  • Preliminary Evidence Indicates Omicron Variant Likely More Transmissible But Less Severe, Fauci Says

    Reuters (12/7, Aboulenein, Heavey, Erman) reports “preliminary evidence indicates that the Omicron variant of the coronavirus likely has a higher degree of transmissibility but is less severe,” according to NIAID Director Dr. Anthony Fauci. While “more da...
    Full Article
  • Omicron Coronavirus Variant May Become Dominant Strain Within Weeks In Parts Of Europe, Experts Say

    The Wall Street Journal (12/7, Douglas, Hinshaw, Subscription Publication) reports the Omicron coronavirus variant is expected to become the dominant strain within weeks in parts of Europe, according to scientists and government officials. This comes as e...
    Full Article
  • Omicron Variant Has Now Been Reported In 50 Countries And 19 States, CDC Director Says

    NPR (12/7, Chappell) reports, “The fast-spreading omicron variant of the coronavirus has now been reported in 50 countries and 19 states, said Dr. Rochelle Walensky, the director of the Centers for Disease Control and Prevention.” Although “officials and...
    Full Article
  • EU May Face Shortage Of Radioactive Isotopes Key To Diagnosing, Treating Diseases, Cancer, Experts Warn

    Reuters (12/7, Guarascio) reports, “The European Union may face a shortage of radioactive isotopes key to diagnosing a range of diseases and treating cancer, according to officials and documents.” While “the EU is the world’s biggest producer of Molybdenu...
    Full Article
  • Oxford-AstraZeneca COVID-19 Vaccine Inventor Warns Next Pandemic “Could Be Worse”

    The Washington Post (12/6, Timsit) reports, “The world should do more now to prepare for future pandemics, said Sarah Gilbert, one of the inventors of the Oxford-AstraZeneca coronavirus vaccine.” During the 44th Richard Dimbleby Lecture, Gilbert said, “Th...
    Full Article
  • US Implements Stricter COVID-19 Testing Rules For International Travelers

    The New York Times (12/6, Jones, Gross) reports, “The United States began requiring international travelers on Monday to provide proof of a negative coronavirus test taken no more than a day before their flights” in an effort “to limit the spread of the O...
    Full Article
  • Omicron Coronavirus Variant May Have Evolved In One Person, Scientists Suggest

    USA Today (12/6, Weintraub) reports that while “no ‘patient zero’ has been found for omicron or any other variant...scientists think they likely evolved within a single immunocompromised person.” Research has “shown that people in treatment for cancer, im...
    Full Article
  • Blood Pressure Of Nearly A Half-Million US Adults Rose During COVID-19 Pandemic, Study Finds

    According to the New York Times (12/6, Rabin), researchers “reported that blood pressure measurements of nearly a half-million adults showed a significant rise last year, compared with the previous year.” The study, published in Circulation, “found that b...
    Full Article
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id